Skip to main content
TipRanks
Go Ultimate75% OFF

Aurora Labs (A3D) AI Stock Analysis

8 Followers
AU:A3D

Aurora Labs

(ASX:A3D)

Select Model
Rating:49Neutral
Price Target:AUD 0.06â–¼(-1.59% Downside)
Action:reiterated
Date:11/13/26

Aurora Labs scores poorly overall, driven by severely weak financial performance: shrinking revenue, negative gross margins, a widening $5.1 million net loss and accelerating cash burn of roughly $4.2 million leave the company reliant on further equity raises and exposed to shareholder dilution. A debt-free balance sheet provides some flexibility but offers limited runway. Valuation adds no cushion given negative earnings and no dividend. The main positive is technical momentum, with the share price trading above all key moving averages on improving MACD and RSI readings — enough to lift the score modestly, but not to offset a speculative, funding-dependent business model.

Positive Factors
Low leverageVery low leverage gives Aurora Labs greater financial flexibility than a highly debt-funded structure. The higher equity position versus FY2025 may provide more capacity to support commercialization and absorb operating volatility, although ongoing losses still limit that flexibility.
Negative Factors
Revenue contractionA material FY2026 revenue decline after only modest growth in FY2025 indicates that demand conversion remains inconsistent. Small, volatile revenue makes it harder to cover fixed costs, plan investment, and establish a dependable base for scaling the commercial model.

Aurora Labs (A3D) vs. iShares MSCI Australia ETF (EWA)

-20%-10%0%10%20%30%40%50%AU:A3D+43.18%EWA+17.02%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
AUD 38.15M
Dividend Yield
―
Average Volume (3M)
562.43K
Price to Earnings (P/E)
-5.7
Beta (1Y)
1.23
Revenue Growth
-24.15%
EPS Growth
-11.22%
Country
Australia
Employees
18
Sector
Industrials
Sector Strength
63
Industry
Industrial - Machinery

Aurora Labs Business Overview & Revenue Model

Company Description

Established in 2014 and headquartered in Canning Vale, Australia, Aurora Labs Limited specializes in the creation, enhancement, and market introduction of 3D metal printers, along with complementary powders, digital components, and relevant intellect...

How the Company Makes Money

Aurora Labs’ revenue model is based on commercializing its metal additive manufacturing technology. The primary expected revenue streams include: (1) sales of metal 3D printing machines/systems to industrial customers; (2) recurring revenue from asso...

Aurora Labs Financial Statement Overview

Summary

Financials are very weak. Revenue fell roughly 20% to about $0.56 million, gross profit swung to negative $3.14 million, and the net loss widened to approximately $5.1 million — the worst in six years. Free cash flow deteriorated to about -$4.16 million with operating outflows of $3.01 million, leaving the company entirely dependent on external funding. The sole offset is a near debt-free balance sheet (debt-to-equity of 0.04) and equity rebuilt to roughly $2.47 million, though that represents well under a year of runway at current burn rates, implying material dilution risk.

Income Statement

6Very Negative

Balance Sheet

42Neutral

Cash Flow

7Very Negative
Financial statement breakdown
BreakdownTTMJun 2026Jun 2025Jun 2024Jun 2023Jun 2022
Income Statement
Total Revenue564.22K564.22K743.83K174.30K134.56K32.20K
Gross Profit-3.14M-3.14M326.65K57.13K58.81K13.89K
EBITDA-5.66M-5.66M-4.40M-3.23M-3.37M-3.70M
Net Income-5.11M-5.11M-3.75M-2.81M-2.96M-3.15M
Balance Sheet
Total Assets4.91M4.91M2.91M3.08M2.18M3.35M
Cash, Cash Equivalents and Short-Term Investments1.98M1.98M1.16M1.65M986.80K1.95M
Total Debt99.74K99.74K956.01K842.94K65.39K160.53K
Total Liabilities2.44M2.44M1.84M1.30M719.35K716.58K
Stockholders Equity2.47M2.47M1.07M1.78M1.46M2.63M
Cash Flow
Free Cash Flow-4.16M-4.16M-2.80M-2.41M-2.60M-2.68M
Operating Cash Flow-3.01M-3.01M-2.62M-2.40M-2.57M-2.63M
Investing Cash Flow-1.15M-1.15M-180.58K-7,690-23.07K-48.42K
Financing Cash Flow5.00M5.00M2.31M3.07M1.63M3.25M

Aurora Labs Technical Analysis

Technical Analysis SentimentPositive
Last Price0.06

Price Trends

50DMA0.05Positive
100DMA0.05Positive
200DMA0.05Positive

Market Momentum

MACD0.00Negative
RSI64.21Neutral
STOCH87.78Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:A3D, the sentiment is Positive. The current price of 0.06 is above the 20-day moving average (MA) of 0.06, above the 50-day MA of 0.05, and above the 200-day MA of 0.05, indicating a bullish trend. The MACD of 0.00 indicates Negative momentum. The RSI at 64.21 is Neutral, neither overbought nor oversold. The STOCH value of 87.78 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:A3D.

Aurora Labs Peers Comparison

Overall Rating

UnderperformOutperform
Sector (63)

Financial Indicators

AU:A3D against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
AU:LBLAU:LBL67NeutralAUD 73.17M14.9411.27%2.60%10.80%26.91%
Sector *63Neutral$10.79B15.437.44%2.01%2.89%-14.66%
AU:A3DAU:A3D49NeutralAUD 38.15M-5.69-149.42%―-24.15%-11.22%
AU:AL3AU:AL346NeutralAUD 61.53M-12.35-14.54%―59.16%48.08%
AU:TTTAU:TTT43NeutralAUD 152.20M-3.46-74.68%―-1.41%-4.04%
AU:MPWAU:MPW30UnderperformAUD 184.67M-12.14-67.53%―-9.99%-245.74%

* Industrials Sector Average

Performance Comparison

-50%-25%0%25%AU:A3DAU:TTTAU:AL3AU:MPWAU:LBLDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
AU:A3D and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
AU:A3DAurora Labs Ltd.0.060.0131.25%
AU:TTTTitomic Ltd0.08-0.14-62.67%
AU:AL3AML3D Ltd0.11-0.07-38.86%
AU:MPWMetal Powder Works Limited1.23-0.92-42.79%
AU:LBLLaserbond Limited0.610.1428.13%

Aurora Labs Corporate Events

Aurora Labs Adopts Constitution by Member Special Resolution

Nov 13, 2026

Aurora Labs Ltd adopted its constitution by special resolution of its members on 13 November 2026. The constitution sets out rules covering shares and options, preference and converting shares, restricted securities, incentive plans, unmarketable par...

Aurora Labs proposes securities issue of options, rights and shares

Nov 13, 2026

Aurora Labs Limited, identified by ASX issuer code A3D, has proposed issuing 18,000,000 unlisted options expiring three years from the date of issue at $0.12, 7,250,000 Performance Rights November 2026 and 1,689,496 ordinary shares. The proposed issu...

Aurora Labs Reports All AGM Resolutions Passed

Nov 13, 2026

Aurora Labs is an industrial technology and innovation company specializing in 3D metal-printed parts for industrial applications, 3D metal printers and related intellectual property. It is also developing advanced propulsion systems for unmanned aer...

Aurora Labs Reports Turbojet Production, Certification and International Evaluation Orders

Nov 12, 2026

Aurora Labs is a printed-propulsion specialist producing additively manufactured turbojet engines for uncrewed and tactical platforms, with activity spanning defence-oriented applications and customers in Australia, Europe, the US and UK. The company...

Aurora Labs Updates Securities Placement Settlement

Nov 5, 2026

Aurora Labs Limited has updated its proposed securities issue arrangements. Part of the settlement originally allocated to the T1 placement has been moved to the T2 placement, revising the timing and structure of the transaction without disclosing ch...

Aurora Labs Applies to Quote 81.99 Million Shares

Nov 5, 2026

Aurora Labs Limited, listed on the ASX under code A3D, applied to quote 81,990,081 fully paid ordinary shares on November 6, 2026. The securities were issued as part of a transaction previously announced to the market, increasing the company’s quoted...

Aurora Labs Secures First UK Defence Engine Sale

Nov 3, 2026

Aurora Labs is an industrial technology company specializing in 3D metal-printed parts, metal printers and related intellectual property, while developing propulsion systems for unmanned aerial systems in the defence market. Its international focus i...

Aurora Labs Secures AS9100D Certification and First U.S. Engine Order as Production Scale-Up Accelerates

Oct 29, 2026

Aurora Labs reported continued progress in shifting from technology development to production scale-up and commercial execution during the September quarter of 2026. The company advanced detailed manufacturing capacity planning, including facility la...

Aurora Labs Plans Major ASX Share and Option Issue to Bolster Capital

Oct 27, 2026

Aurora Labs Limited has announced a proposed issue of securities on the ASX, including up to 83,000,005 ordinary fully paid shares under its A3D ticker. The issuance structure is designed to leverage public market access and equity financing as part...

Aurora Labs Raises $6m to Scale Defence Propulsion Manufacturing

Oct 27, 2026

Aurora Labs Limited is an Australian advanced manufacturing company focused on metal additive manufacturing and proprietary turbojet propulsion systems for defence and aerospace customers. Operating from a vertically integrated, AS9100D-certified fac...

Aurora Labs Halts ASX Trading Ahead of Material Private Placement Announcement

Oct 25, 2026

Aurora Labs Limited has requested and received a trading halt on its ASX-listed securities, with the halt in place until either the release of a forthcoming announcement or the market’s reopening on Wednesday, 28 October 2026. The halt was initiated...

Aurora Labs lands first U.S. turbojet engine sale

Oct 21, 2026

Aurora Labs has secured its first U.S. order for three AU4 turbojet engines and integration services from a U.S.-based aerospace and defence-focused start-up, in a package valued at US$42,000. The engines will support an experimental aircraft program...

Aurora Labs Issues 7.5 Million Unlisted Options in Capital Structure Move

Oct 20, 2026

Aurora Labs Limited has issued 7.5 million unlisted options, exercisable at $0.12 and expiring on October 20, 2029, as part of a previously announced transaction. The new options, which will not be quoted on the ASX, expand the company’s pool of unqu...

Aurora Labs Sets Terms for 7.5 Million Consultant Options

Oct 19, 2026

Aurora Labs has detailed the terms for 7.5 million options to be issued, each convertible into one ordinary share at an exercise price of $0.12 and expiring three years from issuance. The options vest in tranches, with an initial 1.25 million vesting...

Aurora Labs Plans Issue of 7.5 Million Unlisted Options

Oct 19, 2026

Aurora Labs Limited has announced a proposed issue of 7.5 million unlisted options, each exercisable at $0.12 and expiring on 20 October 2029, as part of a placement or other type of securities issue. The move signals the company’s continued use of e...

Aurora Labs Sets November AGM to Vote on Directors and Remuneration Report

Oct 13, 2026

Aurora Labs Ltd has called its Annual General Meeting for 13 November 2026 in Perth, urging shareholders to lodge proxy votes ahead of the session to ensure their participation in key governance decisions. Eligibility to vote is set by the share regi...

Aurora Labs Reshapes Leadership to Drive Defence Manufacturing Push

Oct 4, 2026

Aurora Labs has overhauled its executive leadership, appointing strategy chief Andrew Garth as chief executive officer and moving former CEO Rebekah Letheby into the newly defined role of chief operating officer. The company says the changes are inte...

Aurora Labs Files Updated Corporate Governance Statement with ASX

Aug 20, 2026

Aurora Labs has lodged its latest corporate governance statement and accompanying Appendix 4G with the ASX for the financial year ended 30 June 2026. The company has opted to host its corporate governance statement on its website, confirming it is ac...

Aurora Labs Details ASX-Aligned Governance Amid Diversity Focus

Aug 20, 2026

Aurora Labs Limited operates in the advanced manufacturing and technology sector, focusing on 3D printing solutions and related systems, with its corporate compliance materials hosted on auroralabs3d.com. The company is listed on the ASX and position...

Aurora Labs Corrects Director Option Expiry in Updated ASX Notice

Aug 17, 2026

Aurora Labs has corrected a previously lodged director’s interest notice relating to options held by Chief Executive Officer and director Rebekah Letheby, clarifying that her 3,000,000 options are exercisable at $0.14 each on or before 15 December 20...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 13, 2026